Trial Quality in Nephrology: How Are We Measuring Up?
- 30 September 2011
- journal article
- editorial
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 58 (3), 335-337
- https://doi.org/10.1053/j.ajkd.2011.06.006
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Loss to Analysis in Randomized Controlled Trials in CKDAmerican Journal of Kidney Diseases, 2011
- CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized TrialsAnnals of Internal Medicine, 2010
- Association of trial registration with the results and conclusions of published trials of new oncology drugsTrials, 2009
- Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional AnalysisPLoS Medicine, 2009
- The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological studyBMJ, 2009
- The intention-to-treat approach in randomized controlled trials: Are authors saying what they do and doing what they say?Clinical Trials, 2007
- Violation of the intent-to-treat principle and rate of missing data in superiority trials assessing structural outcomes in rheumatic diseasesArthritis & Rheumatism, 2005
- Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authorsBMJ, 2005
- Investigating patient exclusion bias in meta-analysisInternational Journal of Epidemiology, 2004
- Empirical Evidence for Selective Reporting of Outcomes in Randomized TrialsJAMA, 2004